TARSUS PHARMACEUTICALS INC has a total of 12 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, foods and drinks and basic materials chemistry are RUBICON RES PVT LTD, NATUREX DBS LLC and EPI HEALTH LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Preservation of human bodies | |
#4 | Fodder |
# | Name | Total Patents |
---|---|---|
#1 | Hickok Shawn D | 7 |
#2 | Azamian Bobak Robert | 7 |
#3 | Vehige Joseph G | 7 |
#4 | Ackermann Douglas Michael | 7 |
#5 | Ackermann Douglas | 4 |
#6 | Hickok Shawn | 4 |
#7 | Azamian Bobak | 4 |
#8 | Vehige Joseph | 3 |
#9 | Douglas Michael Ackermann | 1 |
#10 | Shawn D Hickok | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020257663A1 | Isoxazoline parasiticide formulations and methods for treating blepharitis | |
WO2020202111A1 | Systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxis | |
KR20200111177A | Isoxazoline anthelmintic preparation and method for treating blepharitis |